Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott gains RX catheter patent extension

This article was originally published in The Gray Sheet

Executive Summary

U.S. Patent and Trademark Office grants Abbott a one-year interim extension Oct. 14 for its coveted rapid-exchange catheter patent, set to expire Oct. 29. Abbott had filed for a nearly three-year extension on July 25 for the patent, which was originally granted to Dr. Paul Yock in 1995 (1"The Gray Sheet" Sept. 1, 2008, p. 3). Competitors AngioScore and Medtronic oppose the extension. PTO believes the patent qualifies for full extension, but FDA has not yet completed its portion of the patent extension review. Abbott's attorneys met with PTO on Sept. 3 to discuss products that utilize the Yock patent; prior litigation involving the patent, including a Medtronic lawsuit and motion to lift an injunction barring Medtronic from using RX catheters; and an Aug. 19 citizen's petition filed by AngioScore opposing the extension. The physician-preferred RX catheter delivery system is particularly important to Medtronic's stent business, the firm says
Advertisement

Related Content

Court lifts Medtronic’s RX catheter injunction
Medtronic, AngioScore Challenge Abbott’s Attempt To Extend Catheter Patent
Medtronic, AngioScore Challenge Abbott’s Attempt To Extend Catheter Patent
Advertisement
UsernamePublicRestriction

Register

MT026682

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel